官方服务：
资源简介：
Oral microbiome as non-invasive biomarkers for diagnosis of autoimmune hepatitis
应用场景：
创建时间：
2020-10-26
相关数据集
广州市第一人民医院自身免疫性肝炎活动度分级评估数据集
本数据集来源于医院信息系统中自身免疫性肝炎相关检验数据，涵盖肝功能指标（ALT、AST、TBIL、ALP、GGT）、免疫Z指标（IgG）以及自身抗体检测结果（ANA）。 数据通过结构化清洗、标准化处理及多指标融合规则建模，构建了一套完整的“原始数据—异常标记—抗体数值化—自免肝评分—活动度分级—临床建议”的数据处理链路。 该数据集可用于临床辅助决策支持、医疗质量管理分析及科研建模等场景，具备良好的
广东省数据知识产权存证登记平台2026-04-29 更新100
Diagnostic performance of the treatment response score to predict incomplete treatment response in untreated AIH-1.
Diagnostic performance of the treatment response score to predict incomplete treatment response in untreated AIH-1.
NIAID Data Ecosystem30
Summary values of ANA, SMA and anti-SLA/LP for all studies and different subgroups.
¢: random-effects model; £: random-effects heterogeneity. 1/2/3: three groups (ANA/SMA/anti-SLA/LP), $/&: subgroups for European/Asian patients of autoimmune hepatitis, ‡/†: subgroups for immunoblot a
NIAID Data Ecosystem20
DataSheet_1_Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis.docx
Autoimmune hepatitis (AIH) is a common cause of liver cirrhosis. To identify the characteristics of the oral microbiome in patients with AIH, we collected 204 saliva samples including 68 AIH patients
NIAID Data Ecosystem30
Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis
Background Autoimmune hepatitis (AIH) is a chronic liver disease of unknown aetiology and characterized by continuing hepatocellular inflammation and necrosis. Autoantibodies represent accessible mark
NIAID Data Ecosystem30
